Inhibition of capping of surface immunoglobulins at femtomolar concentrations of adriamycin, compound ICRF-159 and tetrodotoxin [proceedings].
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000276:immunology*; D004317:Doxorubicin / Q000494:pharmacology*; D007136:Immunoglobulins / Q000096:biosynthesis*; D007152:Immunologic Capping / Q000187:drug effects*; D007700:Kinetics; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D051379:Mice; D010879:Piperazines / Q000494:pharmacology*; D011929:Razoxane / Q000494:pharmacology*; D013779:Tetrodotoxin / Q000494:pharmacology*
D007136:Immunoglobulins; D010879:Piperazines; D013779:Tetrodotoxin; D011929:Razoxane; D004317:Doxorubicin